Drug Discovery
ByDoes the U.S. Exit from WHO Redefine Global Health Governance? Washington Completes Historic Withdrawal
23 January 2026 Executive Summary The United States has formally completed its withdrawal from the World Health Organization…
Is Partnership-Led Innovation Replacing M&A in Oncology? BMS and Janux Strike $850 Million T-Cell Engager Deal
January 2026 Executive Summary Bristol Myers Squibb (BMS) has entered into a strategic collaboration with Janux Therapeutics, a…
Is Partnership-Led Innovation Replacing M&A in Oncology? BMS and Janux Strike $850 Million T-Cell Engager Deal
22 January 2026 Executive Summary Bristol Myers Squibb (BMS) has entered into a strategic collaboration with Janux Therapeutics,…
Can Global Partnerships Future-Proof Epidemic Preparedness? SK bioscience, Merck (MSD), and Hilleman Unite to Strengthen Ebola Vaccine Supply
23 January 2026 Executive Summary A global vaccine partnership has been established between SK bioscience, MSD (Merck &…
BioNextAI Media Report: Keytruda’s Ovarian Cancer Combo Triumph—28% Survival Boost Lifts Merck Stock 4% Amid Patent Shadow
Published by BioNextAI Media – Merck’s KEYTRUDA (pembrolizumab) delivered compelling Phase 3 data from combination regimens in ovarian cancer,…
BioNextAI Media Report: Merck’s Gardasil Cuts—$200M Savings, 150 Layoffs Amid 5-10% Demand Drop
Published by BioNextAI Media – In a calculated response to softening markets, Merck is halting production of its HPV…
